HomeGilead Sciences

Gilead Sciences

Is GILD Stock a Buy Near 52-Week Lows for Its 4% Yield?

Is GILD Stock a Buy Near 52-Week Lows for Its 4% Yield?

February 21, 2024

Gilead Trodelvy Has Shown Promise in Breast Cancer Patients’ Clinical Trials, Regardless of HER2 Mutation

Gilead Trodelvy Has Shown Promise in Breast Cancer Patients’ Clinical Trials, Regardless of HER2 Mutation

September 5, 2022

3 Healthcare Equities That May Benefit From Senate Democrats’ $21 Billion Proposal in New COVID-19 Funding

3 Healthcare Equities That May Benefit From Senate Democrats’ $21 Billion Proposal in New COVID-19 Funding

August 4, 2022